Ledger.Open graph →
SEC Form D · filed April 11, 2012

BioAegis Therapeutics, Inc

Offering
$6.0M
Sold
$497K
Exemption
—
Industry
Biotechnology
Location
MORRISTOWN, NJ
Type
—

People & firms on this filing (5)

Steven Cordovano · Rowayton, CTExecNicholas D. Smith · SEBASTOPOL, CAExec · DirectorValerie Ceva · New York, NYExec · DirectorSteven Cordovano · North Brunswick, NJExecThomas Stossel · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗